Collagenase in the Treatment of Cellulite

This study is currently recruiting participants.

Verified by Stony Brook University, November 2005

First Received: November 30, 2005 Last Updated: December 6, 2005 History of Changes

Sponsors and Collaborators:	Stony Brook University Biospecifics Technologies Corp.
Information provided by:	Stony Brook University
ClinicalTrials.gov Identifier:	NCT00261144

Purpose

The purpose of this study is to determine if collagenase injection will reduce or eliminate the appearance of cellulite of the thigh.

Condition	Intervention	Phase
Cellulite	Drug: Collagenase	Phase II

Study Type:	Interventional
Study Design:	Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study
Official Title:	Collagenase in the Treatment of Cellulite

Resource links provided by NLM:

Drug Information available for: Collagenase

Further study details as provided by Stony Brook University:

Primary Outcome Measures:

Estimated Enrollment:	10
Study Start Date:	January 2005
Estimated Study Completion Date:	March 2006

Detailed Description:

This is an open label study of collagenase injection therapy for reduction and/or elimination of cellulite of the posterolateral thighs.

Eligibility

Criteria

Inclusion Criteria:

Exclusion Criteria:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00261144

Contacts

Contact: Marie A Badalamente, PhD	631 444 2215	mbadalamente@notes.cc.sunysb.edu
Contact: Gail Trocchio	631 444 2215	gtrocchio@notes.cc.sunysb.edu

Locations

United States, New York
Dept. Orthopaedics, SUNY Stony Brook	Recruiting
Stony Brook, New York, United States, 11794
Contact: Marie A Badalamente, PhD 631-444-2215 mbadalamente@notes.cc.sunysb.edu
Contact: Gail Trocchio 631 444 2215 gtrocchio@notes.cc.sunysb.edu
Principal Investigator: Marie A Badalamente, PhD
Principal Investigator: Alexander B Dagum, MD

Sponsors and Collaborators

Stony Brook University

Biospecifics Technologies Corp.

Investigators

Principal Investigator:	Marie A Badalamente, PhD	Dept. Orthopaedics, SUNY@Stony Brook, NY 11794
Principal Investigator:	Alexander B Dagum, MD	Dept. Surgery, SUNY@Stony Brook, NY 11794

More Information

No publications provided

Study ID Numbers:	Cell 101
Study First Received:	November 30, 2005
Last Updated:	December 6, 2005
ClinicalTrials.gov Identifier:	NCT00261144 History of Changes
Health Authority:	United States: Food and Drug Administration

ClinicalTrials.gov processed this record on July 02, 2009